Paper · 38017477
miR-590-5p/Tiam1-mediated glucose metabolism promotes malignant evolution of pancreatic cancer by regulating SLC2A3 stability.
Liu Y and 6 others. Cancer Cell Int, 2023. Cited by 10 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. miR-590-5p/Tiam1-mediated glucose metabolism promotes malignant evolution of pancreatic cancer by regulating SLC2A3 stability. Papers, record 38017477. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38017477
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- miR-590-5p/Tiam1-mediated glucose metabolism promotes malignant evolution of pancreatic cancer by regulating SLC2A3 stability.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| JJKH20220554KJ | Project of The Education Department of Jilin Province | PubMed | ||
| 210101207 | This research was supported by the Projects of Science and Technology Department of Jilin Province | PubMed | ||
| 20210101423JC | This research was supported by the Projects of Science and Technology Department of Jilin Province | PubMed | ||
| 82360576 | The National Natural Science Foundation of China | PubMed |
Source PubMed
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36,650,758 | An integrative pan-cancer analysis reveals the carcinogenic effects of NCAPH in human cancer. | Math Biosci Eng | 2023 | https://conductscience.org/library/papers/36650758 | PubMed |
| 2 | 34,216,688 | Advances in the epidemiology of pancreatic cancer: Trends, risk factors, screening, and prognosis. | Cancer Lett | 2021 | https://conductscience.org/library/papers/34216688 | PubMed |
| 3 | 34,758,330 | TIAM1-RAC1 promote small-cell lung cancer cell survival through antagonizing Nur77-induced BCL2 conformational change. | Cell Rep | 2021 | https://conductscience.org/library/papers/34758330 | PubMed |
| 4 | 35,310,934 | miR-590-5p Overexpression Alleviates β-Amyloid-Induced Neuron Damage via Targeting Pellino-1. | Anal Cell Pathol (Amst) | 2022 | https://conductscience.org/library/papers/35310934 | PubMed |
| 5 | 35,398,344 | Pancreatic Cancer: Pathogenesis, Screening, Diagnosis, and Treatment. | Gastroenterology | 2022 | https://conductscience.org/library/papers/35398344 | PubMed |
| 6 | 36,734,882 | MiR-181a-5p promotes osteogenesis by targeting BMP3. | Aging (Albany NY) | 2023 | https://conductscience.org/library/papers/36734882 | PubMed |
| 7 | 35,240,055 | Loss-of-function variants in TIAM1 are associated with developmental delay, intellectual disability, and seizures. | Am J Hum Genet | 2022 | https://conductscience.org/library/papers/35240055 | PubMed |
| 8 | 32,591,905 | Structure, function and regulation of mammalian glucose transporters of the SLC2 family. | Pflugers Arch | 2020 | https://conductscience.org/library/papers/32591905 | PubMed |
| 9 | 36,519,542 | TIAM1-mediated synaptic plasticity underlies comorbid depression-like and ketamine antidepressant-like actions in chronic pain. | J Clin Invest | 2022 | https://conductscience.org/library/papers/36519542 | PubMed |
| 10 | 37,392,283 | MiR-590-5p promotes cisplatin resistance via targeting hMSH2 in ovarian cancer. | Mol Biol Rep | 2023 | https://conductscience.org/library/papers/37392283 | PubMed |
1 to 10 of 45
See all 45 referencesCited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,195,364 | Research Progress on the Regulation of Glycolysis in Gastric Cancer: Key Genes and Enzymes. | Int J Gen Med | 2025 | https://conductscience.org/library/papers/41195364 | PubMed |
| 41,051,622 | MicroRNA signatures of invasiveness in PitNETs: a focus on miR-186-5p, miR-191-5p, miR-454-3p, and miR-590-5p. | Endocrine | 2025 | https://conductscience.org/library/papers/41051622 | PubMed |
| 40,842,856 | Identification of Key Glycolysis-Related Genes in Osteoarthritis and Their Correlation with Immune Infiltration Using Bioinformatics Analysis and Machine Learning. | Open Access Rheumatol | 2025 | https://conductscience.org/library/papers/40842856 | PubMed |
| 40,579,785 | Decoding the pancreatic cancer microenvironment: The multifaceted regulation of microRNAs. | Clin Transl Med | 2025 | https://conductscience.org/library/papers/40579785 | PubMed |
| 40,471,218 | Implications of miRNA-590 dysregulation in digestive tract malignancies: mechanistic aspects and clinical significance. | Mol Biol Rep | 2025 | https://conductscience.org/library/papers/40471218 | PubMed |
| 40,419,852 | A prognostic model for head and neck squamous cell carcinoma based on radiotherapy sensitivity insights from nasopharyngeal carcinoma. | Discov Oncol | 2025 | https://conductscience.org/library/papers/40419852 | PubMed |
| 39,974,379 | Development and validation of a prognostic model based on disulfidptosis-related ferroptosis genes: DRD4 and SLC2A3 as biomarkers for predicting prognosis in colon cancer. | Transl Cancer Res | 2025 | https://conductscience.org/library/papers/39974379 | PubMed |
| 39,684,631 | HOXA11-As Promotes Lymph Node Metastasis Through Regulation of IFNL and HMGB Family Genes in Pancreatic Cancer. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39684631 | PubMed |
Genes23
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| BLNK | 29,760 | PubTator's text mining | https://conductscience.org/library/genes/29760 | NCBI Gene |
| CDH1 | 999 | PubTator's text mining | https://conductscience.org/library/genes/999 | NCBI Gene |
| ENO1 | 2,023 | PubTator's text mining | https://conductscience.org/library/genes/2023 | NCBI Gene |
| HK2 | 3,099 | PubTator's text mining | https://conductscience.org/library/genes/3099 | NCBI Gene |
| LDHA | 3,939 | PubTator's text mining | https://conductscience.org/library/genes/3939 | NCBI Gene |
| MIR21 | 406,991 | PubTator's text mining | https://conductscience.org/library/genes/406991 | NCBI Gene |
| MIR215 | 406,997 | PubTator's text mining | https://conductscience.org/library/genes/406997 | NCBI Gene |
| MMP2 | 4,313 | PubTator's text mining | https://conductscience.org/library/genes/4313 | NCBI Gene |
| MMP9 | 4,318 | PubTator's text mining | https://conductscience.org/library/genes/4318 | NCBI Gene |
1 to 10 of 23
See all 23 genesDrugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38017477
GET https://conductscience.org/api/papers/v1/38017477/references?page=2